Article

New 3D monitor vision test assesses stereopsis

New 3D monitor

A new random-dot stereotest using a 3D display and infrared oculography has been found to assess stereopsis objectively in children aged more than 3 years, according to an article published in the November issue of Investigative Ophthalmology & Visual Science.

The study involved 56 children, 38 with various visual impairments and 18 with normal vision. The random-dot stimulus was presented on an autostereoscopic display, which allows viewing of color 3D images. The stimulus recognition was objectively assessed using infrared photo-oculography. The overall accuracy of the test was found to be 95%.The new test setting was developed by Daniel Mojon, MD, FEBO, and the stimulus presentation algorithm was developed by Xiaoyi Jiang, PhD.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.